Chargement en cours...
The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
Hepatocellular carcinoma (HCC) is a primary concern for patients with chronic hepatitis B (CHB). Antiviral therapy has been reasonably the focus of interest for HCC prevention, with most studies reporting on the role of the chronologically preceding agents, interferon-alfa and lamivudine. The impact...
Enregistré dans:
| Publié dans: | Clin Mol Hepatol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Korean Association for the Study of the Liver
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066383/ https://ncbi.nlm.nih.gov/pubmed/27729632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0045 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|